These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9600666)

  • 1. Exogenous nitric oxide reduces oxygen consumption of isolated ventricular myocytes less than other forms of guanylate cyclase stimulation.
    Gong GX; Weiss HR; Tse J; Scholz PM
    Eur J Pharmacol; 1998 Mar; 344(2-3):299-305. PubMed ID: 9600666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic GMP decreases cardiac myocyte oxygen consumption to a greater extent under conditions of increased metabolism.
    Gong GX; Weiss HR; Tse J; Scholz PM
    J Cardiovasc Pharmacol; 1997 Oct; 30(4):537-43. PubMed ID: 9335417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cGMP level that reduces cardiac myocyte O2 consumption is altered in renal hypertension.
    Straznicka M; Gong G; Tse J; Scholz PM; Weiss HR
    Am J Physiol; 1997 Oct; 273(4):H1949-55. PubMed ID: 9362265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between decreased function and O2 consumption caused by cyclic GMP in cardiac myocytes and L-type calcium channels.
    Yan L; Gong GX; Tse J; Scholz PM; Weiss HR
    Res Exp Med (Berl); 1998 Oct; 198(3):109-21. PubMed ID: 9820898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative metabolic effects of cyclic GMP in quiescent cardiomyocytes are not related to L-type calcium channel activity.
    Yan L; Gong GX; Scholz PM; Tse J; Weiss HR
    Res Exp Med (Berl); 1998 Oct; 198(3):123-32. PubMed ID: 9820899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy.
    Rabindranauth P; Naim KL; Scholz PM; Tse J; Sadoff JD; Weiss HR
    Basic Res Cardiol; 1997 Feb; 92(1):8-16. PubMed ID: 9062647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered effects of acetylcholine on cyclic AMP and GMP induced changes in O2 consumption of hypertrophic dog cardiac myocytes.
    Gong GX; Straznicka M; Weiss HR; Tse J; Scholz PM
    J Auton Pharmacol; 1999 Feb; 19(1):19-28. PubMed ID: 10385266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
    Sadoff JD; Scholz PM; Tse J; Weiss HR
    J Clin Invest; 1996 Aug; 98(3):838-45. PubMed ID: 8698876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
    Davidov T; Weiss HR; Tse J; Scholz PM
    Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing cyclic GMP exerts similar positive functional effects on cardiac myocytes regardless of initial level.
    Yan L; Huang MW; Scholz PM; Weiss HR
    Pharmacology; 2000 Jul; 61(1):51-6. PubMed ID: 10895081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells.
    Hinz B; Schröder H
    Pharm Res; 1999 May; 16(5):633-6. PubMed ID: 10350003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
    Mülsch A; Busse R; Bassenge E
    Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation.
    Méry PF; Pavoine C; Belhassen L; Pecker F; Fischmeister R
    J Biol Chem; 1993 Dec; 268(35):26286-95. PubMed ID: 7902837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol-induced reduction in myocardial oxygen consumption can be attenuated by inhibiting guanylyl cyclase.
    Lazar MJ; Patel K; Scholz PM; Weiss HR
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):512-9. PubMed ID: 11588521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase.
    Leitman DC; Agnost VL; Tuan JJ; Andresen JW; Murad F
    Biochem J; 1987 May; 244(1):69-74. PubMed ID: 2889449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced myocardial cyclic GMP increases myocardial O2 consumption in control but not renal hypertension-induced cardiac hypertrophy.
    Sadoff JD; Scholz PM; Tse J; Weiss HR
    Cardiovasc Res; 1997 Dec; 36(3):453-9. PubMed ID: 9534866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the vasodilator action of SIN-1 by the endothelium.
    Busse R; Pohl U; Mülsch A; Bassenge E
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S81-5. PubMed ID: 2484706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of endothelial guanylate cyclase inhibits cellular reactivity.
    Heller R; Bussolino F; Ghigo D; Pescarmona GP; Calvino R; Gasco A; Till U; Bosia A
    Agents Actions Suppl; 1995; 45():177-81. PubMed ID: 7717176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanism of NO release from sydnonimines.
    Feelisch M; Ostrowski J; Noack E
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S13-22. PubMed ID: 2484692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous modification of nitrovasodilator-induced cyclic GMP formation in human lymphocytes.
    Vuorinen P
    Pharmacol Toxicol; 1992 Jun; 70(6 Pt 1):463-7. PubMed ID: 1359526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.